Scholarlink

Background <p>Huang-Lian-Jie-Du decoction (HLJDD), a typical formulation for heat clearance and detoxification, shows therapeutic potential for oral diseases and cognitive impairment. Nevertheless, the mechanism by which HLJDD influences periodontitis-induced cognitive impairment via the microbiota-gut-brain axis remains unknown.</p> Aim of the study <p>We investigated HLJDD’s neuroprotective effects in periodontitis rats, focusing on its modulation of the microbiota-gut-brain axis and underlying molecular mechanisms.</p> Materials and methods <p>Chemical profiling of HLJDD was performed via UHPLC-Q-Exactive Orbitrap HRMS. Periodontitis was induced in SD rats using ligatures and <i>Porphyromonas gingivalis</i> for 2&#xa0;weeks, followed by 8-week treatments with HLJDD (0.75/1.5/3&#xa0;g/kg/day), doxycycline (10&#xa0;mg/kg/day), or vehicle. Alveolar bone loss was assessed via micro-CT, while cognitive function was assessed via the Morris water maze (MWM). Hippocampal and colon pathology was analyzed via H&amp;E, Nissl staining, and immunohistochemistry. The composition of gut microbiota was analyzed by 16S rDNA sequencing. The tight junction proteins in hippocampus and colon were examined by RT- qPCR and immunofluorescence (IF). Inflammatory cytokine levels in intestinal and hippocampus tissue and serum were quantified by ELISA. Network pharmacology predicted potential mechanisms, and Western blotting assessed TLR4/NF-κB pathway proteins.</p> Results <p>HLJDD contained 94 bioactive compounds and significantly attenuated alveolar bone loss, improved cognitive function, and reduced neuronal damage and Aβ deposition. It restored gut microbiota homeostasis, enhanced intestinal and blood–brain barrier integrity, and suppressed neuroinflammation by modulating pro- and anti-inflammatory cytokines. Mechanistically, HLJDD inhibited TLR4/NF-κB signaling, suggesting its therapeutic potential in periodontitis-related cognitive impairment.</p> Conclusion <p>HLJDD ameliorates cognitive impairment in periodontitis by modulating the microbiota-gut-brain axis, reducing neuroinflammation, and inhibiting TLR4/NF-κB activation. These findings support its potential as a novel therapeutic strategy for periodontitis-associated cognitive impairment.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Huang-Lian-Jie-Du decoction alleviates cognitive impairment in periodontitis rats through restoring microbiota-gut-brain axis and inhibiting neuroinflammation via TLR4/NF-κB pathway

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月23日

查看全文
  • Mingqi Chen,
  • Jie Li,
  • Pan Ren,
  • Sixiang Yang,
  • Furong Zhong,
  • Yue Zhu,
  • Yiran Fan,
  • Jinxin Chen,
  • Manru Xu,
  • Wenbin Wu

摘要

Background

Huang-Lian-Jie-Du decoction (HLJDD), a typical formulation for heat clearance and detoxification, shows therapeutic potential for oral diseases and cognitive impairment. Nevertheless, the mechanism by which HLJDD influences periodontitis-induced cognitive impairment via the microbiota-gut-brain axis remains unknown.

Aim of the study

We investigated HLJDD’s neuroprotective effects in periodontitis rats, focusing on its modulation of the microbiota-gut-brain axis and underlying molecular mechanisms.

Materials and methods

Chemical profiling of HLJDD was performed via UHPLC-Q-Exactive Orbitrap HRMS. Periodontitis was induced in SD rats using ligatures and Porphyromonas gingivalis for 2 weeks, followed by 8-week treatments with HLJDD (0.75/1.5/3 g/kg/day), doxycycline (10 mg/kg/day), or vehicle. Alveolar bone loss was assessed via micro-CT, while cognitive function was assessed via the Morris water maze (MWM). Hippocampal and colon pathology was analyzed via H&E, Nissl staining, and immunohistochemistry. The composition of gut microbiota was analyzed by 16S rDNA sequencing. The tight junction proteins in hippocampus and colon were examined by RT- qPCR and immunofluorescence (IF). Inflammatory cytokine levels in intestinal and hippocampus tissue and serum were quantified by ELISA. Network pharmacology predicted potential mechanisms, and Western blotting assessed TLR4/NF-κB pathway proteins.

Results

HLJDD contained 94 bioactive compounds and significantly attenuated alveolar bone loss, improved cognitive function, and reduced neuronal damage and Aβ deposition. It restored gut microbiota homeostasis, enhanced intestinal and blood–brain barrier integrity, and suppressed neuroinflammation by modulating pro- and anti-inflammatory cytokines. Mechanistically, HLJDD inhibited TLR4/NF-κB signaling, suggesting its therapeutic potential in periodontitis-related cognitive impairment.

Conclusion

HLJDD ameliorates cognitive impairment in periodontitis by modulating the microbiota-gut-brain axis, reducing neuroinflammation, and inhibiting TLR4/NF-κB activation. These findings support its potential as a novel therapeutic strategy for periodontitis-associated cognitive impairment.

Graphical Abstract